Parkinson’s Disease Prevalence Worldwide

The Parkinson’s Protocol™ By Jodi Knapp Parkinson’s disease cannot be eliminated completely but its symptoms can be reduced, damages can be repaired and its progression can be delayed considerably by using various simple and natural things. In this eBook, a natural program to treat Parkinson’s disease is provided online. it includes 12 easy steps to repair your body and reduce the symptoms of this disease.

Parkinson’s Disease Prevalence Worldwide

The prevalence of Parkinson’s disease (PD) is increasing globally, largely due to aging populations and improved diagnostic capabilities. Parkinson’s disease is now recognized as the second most common neurodegenerative disorder after Alzheimer’s disease. Here’s a detailed look at the global prevalence of Parkinson’s disease:

Global Prevalence of Parkinson’s Disease

Overall Prevalence: As of recent estimates, over 10 million people worldwide are living with Parkinson’s disease. This number is expected to grow due to the rising proportion of elderly populations globally.
Incidence: Approximately 1-2 out of every 1,000 people are affected by Parkinson’s disease worldwide. The incidence increases significantly with age.

Regional Prevalence

The prevalence of Parkinson’s disease varies across different regions and populations, influenced by factors such as aging, genetics, and environmental exposure.

North America:
- The prevalence of Parkinson’s in the United States is estimated at about 1 million people.
- The incidence rate in the U.S. is around 14-16 per 100,000 people annually.
- Canada’s prevalence is similar, with an estimated 100,000 people affected by Parkinson’s.
Europe:
- Europe has a significant Parkinson’s disease burden, with estimates suggesting around 1.2 million people affected across the continent.
- Countries like the UK, Germany, and Italy have particularly high prevalence rates due to their aging populations.
- The incidence rate is roughly 12-20 per 100,000 people annually, with variation across countries.
Asia:
- Parkinson’s disease is also on the rise in Asia, particularly in countries with rapidly aging populations, such as China, Japan, and South Korea.
- In China, an estimated 2.5 million people have Parkinson’s, making it the country with the largest number of affected individuals. This figure is expected to rise due to the country’s growing elderly population.
- In Japan, about 200,000-300,000 people are affected by Parkinson’s, with a prevalence of approximately 100-200 per 100,000 people over the age of 65.
- In India, Parkinson’s disease is less prevalent than in Western countries, but the number of cases is increasing as life expectancy rises. Estimates suggest that 400,000-600,000 people may be affected.
Africa:
- Data on Parkinson’s disease in Africa is more limited, but it is estimated that Parkinson’s is less common in African countries compared to Western populations.
- The prevalence is believed to be lower due to shorter life expectancy, but with improving healthcare, the number of Parkinson’s patients is expected to rise.
Latin America:
- Latin American countries are experiencing a growing number of Parkinson’s cases due to aging populations.
- In Brazil, it is estimated that around 200,000 people have Parkinson’s disease.
- The prevalence across Latin America is generally lower than in Europe and North America, but it is projected to increase in the coming decades as life expectancy continues to improve.

Age-Related Prevalence

Parkinson’s disease predominantly affects older adults, with most cases occurring in individuals over the age of 60.
The prevalence of Parkinson’s disease increases with age, affecting about:
- 1% of people over 60.
- 4-5% of people over 85.
Early-onset Parkinson’s disease (diagnosed before the age of 50) accounts for about 10-20% of cases.

Sex Differences

Parkinson’s disease is more common in men than in women. Men are approximately 1.5 times more likely to develop the disease than women, though the reasons for this disparity are not fully understood.

Rising Global Burden

Due to aging populations, especially in high- and middle-income countries, the number of people affected by Parkinson’s disease is expected to more than double by 2040. This rise will be particularly notable in regions like Asia and Latin America, where demographic changes are most pronounced.
Environmental factors such as exposure to pesticides, heavy metals, and industrial chemicals, as well as lifestyle factors, may also contribute to an increasing number of cases in certain regions.

Challenges in Low- and Middle-Income Countries

In low- and middle-income countries, Parkinson’s disease may be underdiagnosed and undertreated due to limited access to healthcare, lack of neurological services, and a focus on addressing communicable diseases.
Despite this, as life expectancy rises in these regions, the prevalence of Parkinson’s is expected to increase significantly, putting additional strain on healthcare systems.

Conclusion

Parkinson’s disease affects over 10 million people worldwide, with its prevalence increasing as populations age. The highest rates are found in North America, Europe, and parts of Asia, but the global burden is expected to grow rapidly in regions like Latin America and Asia in the coming decades. Although Parkinson’s primarily affects older adults, the growing number of cases worldwide underscores the need for improved awareness, diagnosis, and treatment options globally.